$ALNY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALNYLAM PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ALNYLAM PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 19 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.14 | 1,875 | 17,138 | 1,875 | 0 to 1.9 K |
Jun 06 2014 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | A | 59.25 | 15,000 | 888,750 | 15,000 | |
Jun 06 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | A | 59.25 | 25,000 | 1,481,250 | 25,000 | |
Jun 06 2014 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | A | 59.25 | 30,000 | 1,777,500 | 30,000 | |
Jun 06 2014 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | A | 59.25 | 15,000 | 888,750 | 15,000 | |
Jun 06 2014 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | A | 59.25 | 15,000 | 888,750 | 15,000 | |
Jun 06 2014 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | A | 59.25 | 15,000 | 888,750 | 15,000 | |
Jun 06 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | A | 59.25 | 15,000 | 888,750 | 15,000 | |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | M | 15.91 | 15,000 | 238,650 | 0 | |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | M | 14.74 | 10,000 | 147,400 | 0 | |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | M | 7.08 | 10,000 | 70,800 | 0 | |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 56.19 | 2,800 | 157,340 | 0 | 2.8 K to 0 (-100.00 %) |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 55.47 | 6,908 | 383,176 | 2,800 | 9.7 K to 2.8 K (-71.16 %) |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 54.21 | 2,500 | 135,536 | 9,708 | 12.2 K to 9.7 K (-20.48 %) |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 52.95 | 22,792 | 1,206,928 | 12,208 | 35 K to 12.2 K (-65.12 %) |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Buy | M | 15.91 | 15,000 | 238,650 | 35,000 | 20 K to 35 K (+75.00 %) |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Buy | M | 14.74 | 10,000 | 147,400 | 20,000 | 10 K to 20 K (+100.00 %) |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Buy | M | 7.08 | 10,000 | 70,800 | 10,000 | 0 to 10 K |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 9.14 | 11,000 | 100,540 | 16,589 | |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 7.10 | 2,500 | 17,750 | 17,500 | |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 58.01 | 10,900 | 632,310 | 3,905 | 14.8 K to 3.9 K (-73.62 %) |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 57.07 | 2,600 | 148,374 | 14,805 | 17.4 K to 14.8 K (-14.94 %) |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 9.14 | 11,000 | 100,540 | 17,405 | 6.4 K to 17.4 K (+171.74 %) |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 7.10 | 2,500 | 17,750 | 6,405 | 3.9 K to 6.4 K (+64.02 %) |
May 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 7.47 | 22,664 | 169,300 | 227,336 | |
May 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 6.78 | 34,170 | 231,673 | 0 | |
May 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 6.78 | 56,834 | 385,335 | 34,170 | |
May 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 56.71 | 2,926 | 165,940 | 106,320 | 109.2 K to 106.3 K (-2.68 %) |
May 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 56.06 | 53,908 | 3,022,287 | 109,246 | 163.2 K to 109.2 K (-33.04 %) |
May 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 7.47 | 22,664 | 169,300 | 163,154 | 140.5 K to 163.2 K (+16.13 %) |
May 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 6.78 | 34,170 | 231,673 | 140,490 | 106.3 K to 140.5 K (+32.14 %) |
May 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 57.64 | 19,500 | 1,124,076 | 106,320 | 125.8 K to 106.3 K (-15.50 %) |
May 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 57.20 | 37,334 | 2,135,639 | 125,820 | 163.2 K to 125.8 K (-22.88 %) |
May 16 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 6.78 | 56,834 | 385,335 | 163,154 | 106.3 K to 163.2 K (+53.46 %) |
Apr 15 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | M | 31.39 | 3,185 | 99,977 | 147,415 | |
Apr 15 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | M | 21.35 | 4,684 | 100,003 | 148,636 | |
Apr 15 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | M | 16.43 | 6,087 | 100,009 | 98,913 | |
Apr 15 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | M | 9.14 | 2,735 | 24,998 | 147,265 | |
Apr 15 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | M | 22.75 | 4,395 | 99,986 | 120,605 | |
Apr 15 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | M | 13.12 | 7,621 | 99,988 | 117,379 | |
Apr 15 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Buy | M | 16.43 | 6,087 | 100,009 | 106,320 | 100.2 K to 106.3 K (+6.07 %) |
Apr 15 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Buy | M | 21.35 | 4,684 | 100,003 | 100,233 | 95.5 K to 100.2 K (+4.90 %) |
Apr 15 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Buy | M | 31.39 | 3,185 | 99,977 | 95,549 | 92.4 K to 95.5 K (+3.45 %) |
Apr 15 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Buy | M | 22.75 | 4,395 | 99,986 | 92,364 | 88 K to 92.4 K (+5.00 %) |
Apr 15 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Buy | M | 13.12 | 7,621 | 99,988 | 87,969 | 80.3 K to 88 K (+9.48 %) |
Apr 15 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Buy | M | 9.14 | 2,735 | 24,998 | 80,348 | 77.6 K to 80.3 K (+3.52 %) |
Mar 27 2014 | ALNY | ALNYLAM PHARMACEUT ... | Sanofi | 10% Owner | Buy | P | 66.88 | 344,448 | 23,036,682 | 9,110,786 | 8.8 M to 9.1 M (+3.93 %) |
Mar 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 12.96 | 22,145 | 286,999 | 0 | |
Mar 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.30 | 6,249 | 58,116 | 31,251 | |
Mar 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.14 | 1,875 | 17,138 | 5,625 | |
Mar 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 7.10 | 2,500 | 17,750 | 17,500 | |
Mar 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 75.15 | 1,944 | 146,094 | 0 | 1.9 K to 0 (-100.00 %) |
Mar 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 74.08 | 22,044 | 1,633,110 | 1,944 | 24 K to 1.9 K (-91.90 %) |
Mar 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 73.34 | 8,781 | 644,020 | 23,988 | 32.8 K to 24 K (-26.80 %) |
Mar 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 7.10 | 2,500 | 17,750 | 32,769 | 30.3 K to 32.8 K (+8.26 %) |
Mar 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.30 | 6,249 | 58,116 | 30,269 | 24 K to 30.3 K (+26.02 %) |
Mar 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.14 | 1,875 | 17,138 | 24,020 | 22.1 K to 24 K (+8.47 %) |
Mar 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 12.96 | 22,145 | 286,999 | 22,145 | 0 to 22.1 K |
Feb 25 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | I | 90.10 | 2,615 | 235,612 | 0 | 2.6 K to 0 (-100.00 %) |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 15.99 | 3,500 | 55,965 | 154,248 | |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 7.10 | 10,000 | 71,000 | 20,000 | |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 81.45 | 400 | 32,579 | 3,905 | 4.3 K to 3.9 K (-9.29 %) |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 80.85 | 5,456 | 441,120 | 4,305 | 9.8 K to 4.3 K (-55.90 %) |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 80.02 | 11,465 | 917,469 | 9,761 | 21.2 K to 9.8 K (-54.01 %) |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 78.62 | 3,079 | 242,071 | 21,226 | 24.3 K to 21.2 K (-12.67 %) |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 15.99 | 3,500 | 55,965 | 24,305 | 20.8 K to 24.3 K (+16.82 %) |
Feb 20 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 7.10 | 10,000 | 71,000 | 20,805 | 10.8 K to 20.8 K (+92.55 %) |
Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 79.74 | 100 | 7,974 | 1,537 | 1.6 K to 1.5 K (-6.11 %) |
Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 79.04 | 2,110 | 166,769 | 1,637 | 3.7 K to 1.6 K (-56.31 %) |
Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 78.08 | 1,540 | 120,249 | 3,747 | 5.3 K to 3.7 K (-29.13 %) |
Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 6.78 | 19,500 | 132,210 | 44,300 | |
Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Payment of Exercise | F | 78.68 | 1,680 | 132,182 | 33,592 | 35.3 K to 33.6 K (-4.76 %) |
Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 6.78 | 19,500 | 132,210 | 35,272 | 15.8 K to 35.3 K (+123.64 %) |
Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | M | 6.78 | 46,331 | 314,124 | 91,004 | |
Feb 04 2014 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Buy | M | 6.78 | 46,331 | 314,124 | 77,613 | 31.3 K to 77.6 K (+148.11 %) |
Jan 27 2014 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Payment of Exercise | F | 89.49 | 2,560 | 229,094 | 5,287 | 7.8 K to 5.3 K (-32.62 %) |
Jan 27 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Payment of Exercise | F | 89.49 | 3,698 | 330,934 | 10,805 | 14.5 K to 10.8 K (-25.50 %) |
Jan 27 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 87.44 | 700 | 61,208 | 0 | 700 to 0 (-100.00 %) |
Jan 27 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 86.60 | 1,100 | 95,260 | 700 | 1.8 K to 700 (-61.11 %) |
Jan 27 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 85.77 | 4,221 | 362,056 | 1,800 | 6 K to 1.8 K (-70.10 %) |
Jan 27 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 84.57 | 1,869 | 158,065 | 6,021 | 7.9 K to 6 K (-23.69 %) |
Jan 27 2014 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Payment of Exercise | F | 89.49 | 4,698 | 420,424 | 7,890 | 12.6 K to 7.9 K (-37.32 %) |
Jan 14 2014 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | M | 15.82 | 15,000 | 237,300 | 0 | |
Jan 14 2014 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Sell | S | 85.36 | 15,000 | 1,280,400 | 0 | 15 K to 0 (-100.00 %) |
Jan 14 2014 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Buy | M | 15.82 | 15,000 | 237,300 | 15,000 | 0 to 15 K |
Jan 03 2014 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | A | 63.86 | 2,823 | 180,277 | 2,823 | |
Jan 03 2014 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Gift | G | 0.00 | 1,750 | 0 | 310,996 | 312.7 K to 311 K (-0.56 %) |
Jan 03 2014 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Gift | G | 0.00 | 1,750 | 0 | 312,746 | 314.5 K to 312.7 K (-0.56 %) |
Jan 03 2014 | ALNY | ALNYLAM PHARMACEUT ... | STARR KEVIN P | Director | Option Exercise | A | 63.86 | 3,670 | 234,366 | 3,670 | |
Jan 03 2014 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Option Exercise | A | 63.86 | 3,670 | 234,366 | 3,670 | |
Jan 03 2014 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | J | 0.00 | 11,512 | 0 | 213,793 | 225.3 K to 213.8 K (-5.11 %) |
Jan 03 2014 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Sell | J | 0.00 | 27,325 | 0 | 225,305 | 252.6 K to 225.3 K (-10.82 %) |
Jan 03 2014 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Buy | J | 0.00 | 11,512 | 0 | 53,106 | 41.6 K to 53.1 K (+27.68 %) |
Jan 03 2014 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILIP A | Director | Buy | J | 0.00 | 27,325 | 0 | 41,594 | 14.3 K to 41.6 K (+191.50 %) |
Jan 03 2014 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | A | 63.86 | 3,388 | 216,358 | 3,388 | |
Jan 03 2014 | ALNY | ALNYLAM PHARMACEUT ... | Ausiello Dennis A | Director | Option Exercise | A | 63.86 | 2,823 | 180,277 | 2,823 | |
Jan 02 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 15.99 | 3,752 | 59,994 | 157,748 | |
Jan 02 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Payment of Exercise | F | 64.51 | 930 | 59,994 | 14,503 | 15.4 K to 14.5 K (-6.03 %) |
Jan 02 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 15.99 | 3,752 | 59,994 | 15,433 | 11.7 K to 15.4 K (+32.12 %) |
Dec 23 2013 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | M | 11.33 | 15,000 | 169,950 | 0 | |
Dec 23 2013 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Sell | S | 65.00 | 15,000 | 975,000 | 0 | 15 K to 0 (-100.00 %) |
Dec 23 2013 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Buy | M | 11.33 | 15,000 | 169,950 | 15,000 | 0 to 15 K |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | A | 63.00 | 5,000 | 315,000 | 5,000 | |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 16.43 | 3,000 | 49,290 | 0 | |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 10.98 | 3,000 | 32,940 | 9,500 | |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 9.14 | 2,000 | 18,280 | 4,563 | |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 60.77 | 2,200 | 133,691 | 7,847 | 10 K to 7.8 K (-21.90 %) |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 60.20 | 5,800 | 349,181 | 10,047 | 15.8 K to 10 K (-36.60 %) |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 16.43 | 3,000 | 49,290 | 15,847 | 12.8 K to 15.8 K (+23.35 %) |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 10.98 | 3,000 | 32,940 | 12,847 | 9.8 K to 12.8 K (+30.47 %) |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 9.14 | 2,000 | 18,280 | 9,847 | 7.8 K to 9.8 K (+25.49 %) |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | A | 63.00 | 20,000 | 1,260,000 | 20,000 | |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | A | 63.00 | 32,500 | 2,047,500 | 32,500 | |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 12.96 | 18,480 | 239,501 | 22,145 | |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.30 | 6,250 | 58,125 | 37,500 | |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.14 | 3,750 | 34,275 | 7,500 | |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 7.10 | 5,000 | 35,500 | 20,000 | |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 61.40 | 9,980 | 612,762 | 12,588 | 22.6 K to 12.6 K (-44.22 %) |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 60.59 | 8,500 | 514,999 | 22,568 | 31.1 K to 22.6 K (-27.36 %) |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 12.96 | 18,480 | 239,501 | 31,068 | 12.6 K to 31.1 K (+146.81 %) |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 60.78 | 4,256 | 258,669 | 12,588 | 16.8 K to 12.6 K (-25.27 %) |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Sell | S | 60.19 | 10,744 | 646,629 | 16,844 | 27.6 K to 16.8 K (-38.94 %) |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 7.10 | 5,000 | 35,500 | 27,588 | 22.6 K to 27.6 K (+22.14 %) |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.30 | 6,250 | 58,125 | 22,588 | 16.3 K to 22.6 K (+38.25 %) |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Buy | M | 9.14 | 3,750 | 34,275 | 16,338 | 12.6 K to 16.3 K (+29.79 %) |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | A | 63.00 | 90,000 | 5,670,000 | 90,000 | |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | M | 6.78 | 11,200 | 75,936 | 47,796 | |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Buy | M | 6.78 | 11,200 | 75,936 | 15,772 | 4.6 K to 15.8 K (+244.97 %) |
Dec 18 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | CEO | Option Exercise | A | 63.00 | 150,000 | 9,450,000 | 150,000 | |
Dec 04 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Option Exercise | M | 7.10 | 3,750 | 26,625 | 7,500 | |
Dec 04 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 62.12 | 1,845 | 114,605 | 7,847 | 9.7 K to 7.8 K (-19.04 %) |
Dec 04 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Sell | S | 61.55 | 1,905 | 117,257 | 9,692 | 11.6 K to 9.7 K (-16.43 %) |
Dec 04 2013 | ALNY | ALNYLAM PHARMACEUT ... | Mason Michael | VP, Finance and Tre ... | Buy | M | 7.10 | 3,750 | 26,625 | 11,597 | 7.8 K to 11.6 K (+47.79 %) |
Nov 15 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 15.99 | 13,500 | 215,865 | 161,500 | |
Nov 15 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 53.36 | 13,500 | 720,302 | 11,681 | 25.2 K to 11.7 K (-53.61 %) |
Nov 15 2013 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 15.99 | 13,500 | 215,865 | 25,181 | 11.7 K to 25.2 K (+115.57 %) |
Oct 24 2013 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | M | 9.30 | 15,000 | 139,500 | 0 | |
Oct 24 2013 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Sell | S | 60.00 | 15,000 | 900,000 | 126,216 | 141.2 K to 126.2 K (-10.62 %) |
Oct 24 2013 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Buy | M | 9.30 | 15,000 | 139,500 | 141,216 | 126.2 K to 141.2 K (+11.88 %) |
Oct 22 2013 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President and COO | Option Exercise | A | 59.31 | 10,000 | 593,100 | 10,000 | |
Oct 15 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 6.78 | 12,665 | 85,869 | 46,331 | |
Oct 15 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 6.78 | 12,665 | 85,869 | 31,282 | 18.6 K to 31.3 K (+68.03 %) |
Sep 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 0.95 | 45,263 | 43,000 | 0 | |
Sep 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 0.95 | 13,684 | 13,000 | 0 | |
Sep 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 57.02 | 1,100 | 62,726 | 18,617 | 19.7 K to 18.6 K (-5.58 %) |
Sep 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 56.33 | 3,800 | 214,070 | 19,717 | 23.5 K to 19.7 K (-16.16 %) |
Sep 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 55.41 | 54,047 | 2,994,728 | 23,517 | 77.6 K to 23.5 K (-69.68 %) |
Sep 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 0.95 | 45,263 | 43,000 | 77,564 | 32.3 K to 77.6 K (+140.13 %) |
Sep 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 0.95 | 13,684 | 13,000 | 32,301 | 18.6 K to 32.3 K (+73.50 %) |
Sep 12 2013 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | EVP, Chief Medical ... | Option Exercise | M | 9.30 | 6,250 | 58,125 | 43,750 |